Código QR (código de barras bidimensional)

Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe): a multicenter prospective trial - trial protocol

Abstract Background Neoadjuvant chemotherapy is used in borderline resectable (BR) and locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC) to increase resection rate and improve cancer outcome. However, there is a need for better prediction of resectability. The aim of this prospective, si...

ver descrição completa

Na minha lista:
Principais autores: Luís Filipe Abreu de Carvalho, Filip Gryspeerdt, Wim Ceelen, Karen Geboes, Suzane Ribeiro, Anne Hoorens, Nele Vandenbussche, Kathleen B.M. Claes, Clarisse Lecluyse, Aliaksandr Anisau, Johan Van Ongeval, Willem Lybaert, Lars Triest, Andrew Vervaecke, Steven Sas, Barbara Claerhout, Carolien Beyls, Mark Sie, Frederik Berrevoet
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2025-05-01
coleção:BMC Surgery
Assuntos:
Pancreatic cancer
Borderline resectable pancreatic cancer
Locally advanced pancreatic cancer
Neoadjuvant chemotherapy
FOLFIRINOX
Liquid biopsy
Acesso em linha:https://doi.org/10.1186/s12893-025-02938-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados